Diversified Healthcare Trust reported strong sequential quarter NOI growth in its same property SHOP segment, driven by increases in rate. Leasing results in the Office Portfolio remained resilient. The company generated $653 million of cash through a new joint venture, bringing the total cash position to approximately $1.5 billion at quarter end.
Reported net income attributable to common shareholders of $240.4 million, or $1.01 per share.
Reported normalized funds from operations, or Normalized FFO, attributable to common shareholders of $(21.9) million, or $(0.09) per share.
Recorded a gain on sale of properties of $327.5 million, or $1.38 per share, from DHC's new joint venture.
As of March 31, 2022, DHC had approximately $1.5 billion of cash and cash equivalents and restricted cash.
DHC anticipates continued growth and recovery, supported by liquidity and strategic investments. However, the company faces risks related to economic conditions, debt compliance, and the performance of its tenants and managers.
Analyze how earnings announcements historically affect stock price performance